Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 340.90
-7.70 (-2.21%)
Apr 13, 2026, 1:06 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 564.16 billion as of April 10, 2026. Its market cap has increased by 37.87% in one year.
Market Cap
564.16B
Enterprise Value
731.00B
Revenue
168.27B
Ranking
n/a
PE Ratio
73.23
Stock Price
340.90
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 564.16B, an increase of 1,142.30%. That is a compound annual growth rate of 12.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 564.16B | 7.33% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 418.06B |
| OneSource Specialty Pharma | 164.93B |
| Concord Biotech | 110.94B |
| Blue Jet Healthcare | 70.57B |
| Supriya Lifescience | 51.41B |
| Zota Health Care | 44.62B |
| Dishman Carbogen Amcis | 24.97B |
| Panacea Biotec | 20.04B |